“Shares of Definium Therapeutics jumped more than 10% Wednesday morning after the biotech company said its experimental psychedelic drug helped reduce anxiety. DT120, a fast-dissolving tablet form of lysergide, was tested in a late-stage trial of 214 people with generalized anxiety disorder. Those taking the drug saw anxiety levels drop by more than those on placebo, Definium said.”

From Wall Street Journal.